Search Ontology:
ChEBI
dihydroergotamine
- Term ID
- CHEBI:4562
- Synonyms
-
- (10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
- 5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
- 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
- 9,10-dihydroergotamine
- dihidroergotamina
- Dihydroergotamine
- dihydroergotaminum
- Definition
- Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension.
- References
-
- beilstein:78887
- cas:511-12-6
- drugbank:DB00320
- drugcentral:888
- kegg.compound:C07798
- kegg.drug:D07837
- knapsack:C00001724
- lincs.smallmolecule:LSM-3619
- pubmed:10954953
- pubmed:20132337
- pubmed:8145914
- wikipedia.en:Dihydroergotamine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from dihydroergotamine
Phenotype where environments contain dihydroergotamine
Phenotype modified by environments containing dihydroergotamine
Phenotype affecting dihydroergotamine
Human Disease Model